In this CME-certified module, Robert M. Rifkin, MD, FACP, and Kenneth G. Saag, MD, MSc, provide their expert answers to your frequently asked questions about biosimilars and their application in clinical practice.
In this CME-certified module, Sanjiv S. Agarwala, MD, and Alan J. Kivitz, MD, CPI, expand on the application of biosimilars to clinical practice by answering questions submitted by learners.
In this downloadable slideset, Sanjiv S. Agarwala, MD; Alan J. Kivitz, MD, CPI; Robert M. Rifkin, MD, FACP; and Kenneth G. Saag, MD, MSc, provide an overview of biosimilars, a new therapeutic class of drugs.
Biosimilars promise increased access and decreased prices for patients in need of expensive biologics. However, as with any new category of drug, biosimilars face some uncertainties. Here’s my take.
The role of biosimilars in the setting of IBD is growing. Here’s my take on some of the key things you need to consider when using these agents.
Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112
Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.